Futibatinib in Combination With (Chemo)Immunotherapy in Colorectal Cancer and Other Solid Tumor Entities
Conditions
Colorectal Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Klinikum St. Marien Amberg, Amberg, Germany
Contact: Study coordinator (Ludwig Fischer von Weikersthal, Dr.)Charité Campus Virchow Klinikum (CVK), Berlin, Germany
Contact: Study coordinator (Dominik P Modest, Prof.)Universitätsklinikum Düsseldorf, Düsseldorf, Germany
Contact: Study coordinator (Christoph Roderburg, Prof.)Kliniken Essen-Mitte, Essen, Germany
Contact: Study coordinator (Christian Müller, Dr.)Krankenhaus Nordwest, Frankfurt am Main, Germany
Contact: Study coordinator (Thorsten O. Götze, Prof. Dr.)Hope Hamburg, Hamburg, Germany
Contact: Study coordinator (Alexander Stein, Prof.)Universitätsmedizin Mainz, Mainz, Germany
Contact: Study coordinator (Markus Möhler, Prof.)Klinikum München rechts der Isar, München, Germany
Contact: Study coordinator (Sylvie Lorenzen, Prof.)MVZ für Hämatologie und Onkologie Ravensburg GmbH, Ravensburg, Germany
Contact: Study coordinator (Tobias Dechow, Prof.)Leopoldina Krankenhaus Schweinfurt, Schweinfurt, Germany
Contact: Study coordinator (Stephan Kanzler, Prof.)
Study leads
Salah Al-Batran, Prof. Dr.
Study Director
Institut für Klinische Krebsforschung IKF GmbH
Thorsten O. Götze, Prof. Dr.
Principal Investigator
Institute of Clinical Cancer Research, UCT - University Cancer Center Frankfurt Krankenhaus Nordwest
Markus Möhler, Prof. Dr.
Principal Investigator
Johannes Gutenberg-University Clinic Mainz